NCT01374113View on ClinicalTrials.gov

Safinamide Renal Impairment Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Conditions
Renal Impairment
Interventions
DRUG

50mg safinamide

50 mg safinamide on Day 1

Trial Locations (1)

Unknown

CRS Clinical Research Services Kiel GmbH, Kiel

Sponsors
All Listed Sponsors
lead

Newron Pharmaceuticals SPA

INDUSTRY

NCT01374113 - Safinamide Renal Impairment Trial | Biotech Hunter | Biotech Hunter